Hospital epidemiology and infection control in acute-care settings

Clinical Microbiology Reviews

Volumn 24, Issue 1, 2011, Pages 141-173

  Sydnor, Emily R M ^a   Perl, Trish M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMANTANE DERIVATIVE; ALCOHOL DERIVATIVE; AMINOPENICILLIN; AZITHROMYCIN; BETA LACTAMASE; BLEACHING AGENT; CARBAPENEMASE; CEPHALOSPORIN; CLARITHROMYCIN; DIPHTHERIA PERTUSSIS TETANUS VACCINE; ERYTHROMYCIN; HEPATITIS B VACCINE; HEPATITIS C VACCINE; HYDROGEN PEROXIDE; PEGINTERFERON ALPHA; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIBAVIRIN; SIALIDASE INHIBITOR;

2009 H1N1 INFLUENZA; ACINETOBACTER; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; ASPERGILLUS; BLOOD TRANSFUSION; CANDIDA; CD4 LYMPHOCYTE COUNT; CLEANING; CLOSTRIDIUM DIFFICILE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONSTRUCTION WORK; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; DISINFECTION; EMERGENCY CARE; ENTEROBACTERIACEAE; ENVIRONMENTAL HEALTH; EPIDEMIC; GRAM NEGATIVE BACTERIUM; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH EDUCATION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTORY; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION CONTROL; INFECTION PREVENTION; INFLUENZA VIRUS; INFUSION; INSTRUMENT STERILIZATION; INVASIVE CANDIDIASIS; LEGIONELLA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MIXED INFECTION; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; MYCOSIS; NONHUMAN; OCCUPATIONAL HEALTH; PANDEMIC; PERTUSSIS; PSEUDOMONAS AERUGINOSA; RENAL REPLACEMENT THERAPY; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RESPIRATORY TRACT INFECTION; SEPSIS; SEROCONVERSION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; SURGICAL INFECTION; VANCOMYCIN RESISTANT ENTEROCOCCUS; VENTILATOR ASSOCIATED PNEUMONIA;

CROSS INFECTION; EMERGENCY SERVICE, HOSPITAL; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; INFECTION CONTROL;

EID: 78751507447     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00027-10     Document Type: Article

References (370)

1. Ahmad, K. 2007. Kazakhstan health workers stand trial for HIV outbreak. Lancet Infect. Dis. 7:311.
2. AIDS/TB Committee of the Society for Healthcare Epidemiology of America. 1997. Management of healthcare workers infected with hepatitis B virus, hepatitis C virus, human immunodeficiency virus, or other bloodborne pathogens. Infect. Control Hosp. Epidemiol. 18:349-363.
3. Albrecht, S. J., et al. 2006. Reemergence of Gram-negative health careassociated bloodstream infections. Arch. Intern. Med. 166:1289-1294.
4. Alter, H. J., et al. 1972. Posttransfusion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors. Ann. Intern. Med. 77:691-699.
5. Alter, M. J. 1994. Occupational exposure to hepatitis C virus: a dilemma. Infect. Control Hosp. Epidemiol. 15:742-744.
6. American Institute of Architects. 2010. Guidelines for design and construction of hospital and health care facilities. Facility Guidelines Institute, Dallas, TX. http://www.fgiguidelines.org/2010guidelines.html.
7. American Thoracic Society and Infectious Diseases Society of America. 2005. Guidelines for the management of adults with hospital-acquired ventilator-associated and healthcare-associated pneumonia. Am. J. Respir. Crit. Care Med. 171:388-416.
8. Amin, A. 2009. Clinical and economic consequences of ventilator- associated pneumonia. Clin. Infect. Dis. 49(Suppl. 1):S36-S43.
9. Anaissie, E. J., et al. 2002. Pathogenic Aspergillus species recovered from a hospital water system: a 3-year prospective study. Clin. Infect. Dis. 34: 780-789.
10. Anderson, D. J., et al. 2008. Strategies to prevent surgical site infections in acute care hospitals. Infect. Control Hosp. Epidemiol. 29(Suppl. 1):S51-S61.
11. Apisarnthanarak, A., et al. 2007. Initial inappropriate urinary catheters use in a tertiary-care center: incidence, risk factors, and outcomes. Am. J. Infect. Control 35:594-599.
12. Arnow, P. M., R. L. Andersen, P. D. Mainous, and E. J. Smith. 1978. Pumonary aspergillosis during hospital renovation. Am. Rev. Respir. Dis. 118:49-53.
13. Babcock, H. M., N. Gemeinhart, M. Jones, W. C. Dunagan, and K. F. Woeltje. 2010. Mandatory influenza vaccination of health care workers: translating policy to practice. Clin. Infect. Dis. 50:459-464.
14. Barnes, R. A., and T. R. Rogers. 1989. Control of an outbreak of nosocomial aspergillosis by laminar air-flow isolation. J. Hosp. Infect. 14:89-94.
15. Bartlett, J. G. 2006. The new epidemic of Clostridium difficile-associated enteric disease. Ann. Intern. Med. 145:758-764.
16. Bassetti, M., et al. 2006. Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect. Dis. 6:21.
17. Bates, C. J., and R. Pearse. 2005. Use of hydrogen peroxide vapour for environmental control during a Serratia outbreak in a neonatal intensive care unit. J. Hosp. Infect. 61:364-366.
18. Bearman, G. M., and R. P. Wenzel. 2005. Bacteremias: a leading cause of death. Arch. Med. Res. 36:646-659.
19. Beltrami, E. M., I. T. Williams, C. N. Shapiro, and M. E. Chamberland. 2000. Risk and management of blood-borne infections in health care workers. Clin. Microbiol. Rev. 13:385-407.
20. Bentley, R. 2005. The development of penicillin: genesis of a famous antibiotic. Perspect. Biol. Med. 48:444-452.
21. Berenholtz, S. M., et al. 2004. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit. Care Med. 32:2014-2020.
22. Bertrand, X., et al. 2001. Endemicity, molecular diversity and colonisation routes of Pseudomonas aeruginosa in intensive care units. Intensive Care Med. 27:1263-1268.
23. Best, E. L., W. N. Fawley, P. Parnell, and M. H. Wilcox. 2010. The potential for airborne dispersal of Clostridium difficile from symptomatic patients. Clin. Infect. Dis. 50:1450-1457.
24. Blanc, D. S., T. Parret, B. Janin, P. Raselli, and P. Francioli. 1997. Nosocomial infections and pseudoinfections from contaminated bronchoscopes: two-year follow up using molecular markers. Infect. Control Hosp. Epidemiol. 18:134-136.
25. Blumberg, H. M., et al. 1995. Preventing the nosocomial transmission of tuberculosis. Ann. Intern. Med. 122:658-663.
26. Bode, L. G., et al. 2010. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N. Engl. J. Med. 362:9-17.
27. Boelaert, J. R., et al. 1989. The influence of calcium mupirocin nasal ointment on the incidence of Staphylococcus aureus infections in haemodialysis patients. Nephrol. Dial. Transplant. 4:278-281.
28. Boelaert, J. R., et al. 1993. Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients. Nephrol. Dial. Transplant. 8:235-239.
29. Bonten, M. J., et al. 1996. Risk factors for pneumonia, and colonization of respiratory tract and stomach in mechanically ventilated ICU patients. Am. J. Respir. Crit. Care Med. 154:1339-1346.
30. Boucher, H. W., and G. R. Corey. 2008. Epidemiology of methicillin-resistant Staphylococcus aureus. Clin. Infect. Dis. 46(Suppl. 5):S344-S349.
31. Boyce, J. M., et al. 2008. Impact of hydrogen peroxide vapor room decontamination on Clostridium difficile environmental contamination and transmission in a healthcare setting. Infect. Control Hosp. Epidemiol. 29:723-729.
32. Boyce, J. M., et al. 1995. Controlling vancomycin-resistant enterococci. Infect. Control Hosp. Epidemiol. 16:634-637.
33. Boyce, J. M., et al. 1994. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J. Clin. Microbiol. 32:1148-1153.
34. Bradford, P. A., et al. 2004. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City. Clin. Infect. Dis. 39:55-60.
35. Brakhage, A. A. 2005. Systemic fungal infections caused by Aspergillus species: epidemiology, infection process and virulence determinants. Curr. Drug Targets 6:875-886.
36. Bratu, S., et al. 2005. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch. Intern. Med. 165:1430-1435.
37. Bratzler, D. W. 2006. The Surgical Infection Prevention and Surgical Care Improvement Projects: promises and pitfalls. Am. Surg. 72:1010-1016, 1021-1030, 1133-1148.
38. Brown, T. T., et al. 2005. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch. Intern. Med. 165:1179-1184.
39. Brumfitt, W., and J. Hamilton-Miller. 1989. Methicillin-resistant Staphylococcus aureus. N. Engl. J. Med. 320:1188-1196.
40. Burke, J. P. 2003. Infection control - a problem for patient safety. N. Engl. J. Med. 348:651-656.
41. Burns, S. M., et al. 2003. Implementation of an institutional program to improve clinical and financial outcomes of mechanically ventilated patients: one-year outcomes and lessons learned. Crit. Care Med. 31:2752-2763.
42. Byers, K. E., et al. 1998. Disinfection of hospital rooms contaminated with vancomycin-resistant Enterococcus faecium. Infect. Control Hosp. Epidemiol. 19:261-264.
43. Calfee, D. P., et al. 2008. Strategies to prevent transmission of methicillinresistant Staphylococcus aureus in acute care hospitals. Infect. Control Hosp. Epidemiol. 29(Suppl. 1):S62-S80.
44. Cardo, D. M., et al. 1997. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. N. Engl. J. Med. 337:1485-1490.
45. Carling, P. C., et al. 2008. Improving cleaning of the environment surrounding patients in 36 acute care hospitals. Infect. Control Hosp. Epidemiol. 29:1035-1041.
46. Carlson, A. L., and T. M. Perl. 2010. Health care workers as source of hepatitis B and C virus transmission. Clin. Liver Dis. 14:153-168.
47. Carmeli, Y., et al. 2010. Controlling the spread of carbapenemase- producing Gram-negatives: therapeutic approach and infection control. Clin. Microbiol. Infect. 16:102-111.
48. Carmeli, Y., G. Eliopoulos, E. Mozaffari, and M. Samore. 2002. Health and economic outcomes of vancomycin-resistant enterococci. Arch. Intern. Med. 162:2223-2228.
49. Carmeli, Y., N. Troillet, A. W. Karchmer, and M. H. Samore. 1999. Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. Arch. Intern. Med. 159:1127-1132.
50. Catalano, G., et al. 2003. Anxiety and depression in hospitalized patients in resistant organism isolation. South. Med. J. 96:141-145.
51. Centers for Disease Control. 1991. Recommendations for preventing transmission of human immunodeficiency virus, hepatitis B virus to patients during exposure-prone invasive procedures. JAMA 266:771, 774-776.
52. Centers for Disease Control and Prevention. 2008. Acute hepatitis C virus infections attributed to unsafe injection practices at an endoscopy clinic - Nevada, 2007. MMWR Morb. Mortal. Wkly. Rep. 57:513-517.
53. Centers for Disease Control and Prevention. 2010. Detection of Enterobacteriaceae isolates carrying metallo-beta-lactamase-United States, 2010. MMWR Morb. Mortal. Wkly. Rep. 59:750.
54. Centers for Disease Control and Prevention. 2002. Exophiala infection from contaminated injectable steroids prepared by a compounding pharmacy - United States July-November 2002. MMWR Morb. Mortal. Wkly. Rep. 51:1109-1112.
55. Centers for Disease Control and Prevention. 1999. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus - Minnesota and North Dakota, 1997-1999. JAMA 282:1123-1125.
56. Centers for Disease Control and Prevention. 2009. Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR Morb. Mortal. Wkly. Rep. 58:256-260.
57. Centers for Disease Control and Prevention. 2000. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Recommend. Rep. 49:1-125.
58. Centers for Disease Control and Prevention. 2009. Interim guidance on infection control measures for 2009 H1N1 influenza in healthcare settings including protection of healthcare personnel. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/h1n1flu/guidelines-infection- control.htm.
59. Centers for Disease Control and Prevention. 2010. Prevention strategies for seasonal influenza in healthcare settings. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/flu/pdf/infectioncontrol- seasonalflu-ICU2010.pdf.
60. Centers for Disease Control and Prevention. 2005. Severe Clostridium difficile-associated disease in populations previously at low risk - four states, 2005. MMWR Morb. Mortal. Wkly. Rep. 54:1201-1205.
61. Centers for Disease Control and Prevention. 1995. Vaccination coverage of 2-year-old children - United States, January-March, 1994. MMWR Morb. Mortal. Wkly. Rep. 44:142-143, 149-150.
62. Cervera, C., M. Almela, J. A. Martinez-Martinez, A. Moreno, and J. M. Miro. 2009. Risk factors and management of Gram-positive bacteraemia. Int. J. Antimicrob. Agents 34(Suppl. 4):S26-S30.
63. Chen, Y. Y., Y. C. Chou, and P. Chou. 2005. Impact of nosocomial infection on cost of illness and length of stay in intensive care units. Infect. Control Hosp. Epidemiol. 26:281-287.
64. Chen, Y. Y., F. D. Wang, C. Y. Liu, and P. Chou. 2009. Incidence rate and variable cost of nosocomial infections in different types of intensive care units. Infect. Control Hosp. Epidemiol. 30:39-46.
65. Christie, C. D., M. L. Marx, C. D. Marchant, and S. F. Reising. 1994. The 1993 epidemic of pertussis in Cincinnati. Resurgence of disease in a highly immunized population of children. N. Engl. J. Med. 331:16-21.
66. Ciesielski, C., et al. 1992. Transmission of human immunodeficiency virus in a dental practice. Ann. Intern. Med. 116:798-805.
67. Clabots, C. R., S. J. Gerding, M. M. Olson, L. R. Peterson, and D. N. Gerding. 1989. Detection of asymptomatic Clostridium difficile carriage by an alcohol shock procedure. J. Clin. Microbiol. 27:2386-2387.
68. Cleveland, J. L., B. F. Gooch, and S. A. Lockwood. 1997. Occupational blood exposures in dentistry: a decade in review. Infect. Control Hosp. Epidemiol. 18:717-721.
69. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing. M100-S19. Clinical and Laboratory Standards Institute, Wayne, PA.
70. Coffey, C. C., D. L. Campbell, and Z. Zhuang. 1999. Simulated workplace performance of N95 respirators. Am. Ind. Hyg. Assoc. J. 60:618-624.
71. Coffin, S. E., et al. 2008. Strategies to prevent ventilator-associated pneumonia in acute care hospitals. Infect. Control Hosp. Epidemiol. 29(Suppl. 1):S31-S40.
72. Cohen, S. H., et al. 2010. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect. Control Hosp. Epidemiol. 31:431-455.
73. Cornet, M., L. Fleury, C. Maslo, J. F. Bernard, and G. Brucker. 2002. Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area. J. Hosp. Infect. 51:288-296.
74. Cortese, M. M., and U. D. Parashar. 2009. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommend. Rep. 58:1-25.
75. Cosgrove, S. E. 2006. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin. Infect. Dis. 42(Suppl. 2):S82-S89.
76. Cosgrove, S. E., et al. 2005. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect. Control Hosp. Epidemiol. 26:166-174.
77. Cosgrove, S. E., et al. 2003. Comparison of mortality associated with methicillin- resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin. Infect. Dis. 36:53-59.
78. Couch, R. B., J. A. Englund, and E. Whimbey. 1997. Respiratory viral infections in immunocompetent and immunocompromised persons. Am. J. Med. 102:2-9, 25-56.
79. Cruz, A. T., A. C. Cazacu, J. M. Greer, and G. J. Demmler. 2008. Rapid assays for the diagnosis of influenza A and B viruses in patients evaluated at a large tertiary care children's hospital during two consecutive winter seasons. J. Clin. Virol. 41:143-147.
80. Darouiche, R. O., et al. 2010. Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N. Engl. J. Med. 362:18-26.
81. Demain, A. L., and R. P. Elander. 1999. The beta-lactam antibiotics: past, present, and future. Antonie Van Leeuwenhoek 75:5-19.
82. Denning, D. W., et al. 1998. An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group. J. Infect. 37:173-180.
83. DiazGranados, C. A., S. M. Zimmer, M. Klein, and J. A. Jernigan. 2005. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin. Infect. Dis. 41:327-333.
84. Digiovine, B., C. Chenoweth, C. Watts, and M. Higgins. 1999. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am. J. Respir. Crit. Care Med. 160:976-981.
85. Do, A. N., et al. 2003. Occupationally acquired human immunodeficiency virus (HIV) infection: national case surveillance data during 20 years of the HIV epidemic in the United States. Infect. Control Hosp. Epidemiol. 24: 86-96.
86. Dubberke, E. R., et al. 2008. Strategies to prevent Clostridium difficile infections in acute care hospitals. Infect. Control Hosp. Epidemiol. 29(Suppl. 1):S81-S92.
87. Dubberke, E. R., and A. I. Wertheimer. 2009. Review of current literature on the economic burden of Clostridium difficile infection. Infect. Control Hosp. Epidemiol. 30:57-66.
88. Dworkin, M. S., et al. 1999. Bordetella bronchiseptica infection in human immunodeficiency virus-infected patients. Clin. Infect. Dis. 28:1095-1099.
89. Edmond, M., and T. C. Eickhoff. 2008. Who is steering the ship? External influences on infection control programs. Clin. Infect. Dis. 46:1746-1750.
90. Edwards, J. R., et al. 2009. National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009. Am. J. Infect. Control 37:783-805.
91. Engelhart, S., A. Glasmacher, M. Exner, and M. H. Kramer. 2002. Surveillance for nosocomial infections and fever of unknown origin among adult hematology-oncology patients. Infect. Control Hosp. Epidemiol. 23:244-248.
92. Engemann, J. J., et al. 2003. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin. Infect. Dis. 36:592-598.
93. Esteban, J. I., et al. 1996. Transmission of hepatitis C virus by a cardiac surgeon. N. Engl. J. Med. 334:555-560.
94. Evans, H. L., et al. 2007. Cost of Gram-negative resistance. Crit. Care Med. 35:89-95.
95. Fahey, B. J., D. E. Koziol, S. M. Banks, and D. K. Henderson. 1991. Frequency of nonparenteral occupational exposures to blood and body fluids before and after universal precautions training. Am. J. Med. 90:145-153.
96. Ferguson, J. K. 2009. Preventing healthcare-associated infection: risks, healthcare systems and behaviour. Intern. Med. J. 39:574-581.
97. Field, M. J. (ed.). 2001. Tuberculosis in the workplace. National Academies Press, Washington, DC.
98. Fischer, T. K., J. S. Bresee, and R. I. Glass. 2004. Rotavirus vaccines and the prevention of hospital-acquired diarrhea in children. Vaccine 22(Suppl. 1):S49-S54.
99. Fishman, J. A. 2007. Infection in solid-organ transplant recipients. N. Engl. J. Med. 357:2601-2614.
100. Flamm, R. K., et al. 2004. Factors associated with relative rates of antibiotic resistance in Pseudomonas aeruginosa isolates tested in clinical laboratories in the United States from 1999 to 2002. Antimicrob. Agents Chemother. 48:2431-2436.
101. Fournier, P. E., and H. Richet. 2006. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin. Infect. Dis. 42:692-699.
102. Frank, U., F. D. Daschner, G. Schulgen, and J. Mills. 1997. Incidence and epidemiology of nosocomial infections in patients infected with human immunodeficiency virus. Clin. Infect. Dis. 25:318-320.
103. French, G. L., et al. 2004. Tackling contamination of the hospital environment by methicillin-resistant Staphylococcus aureus (MRSA): a comparison between conventional terminal cleaning and hydrogen peroxide vapour decontamination. J. Hosp. Infect. 57:31-37.
104. Friis-Moller, N., et al. 2003. Cardiovascular disease risk factors in HIV patients - association with antiretroviral therapy. Results from the DAD study. AIDS 17:1179-1193.
105. Ganczak, M., and P. Barss. 2008. Nosocomial HIV infection: epidemiology and prevention - a global perspective. AIDS Rev. 10:47-61.
106. Garbutt, J. M., M. Ventrapragada, B. Littenberg, and L. M. Mundy. 2000. Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia. Clin. Infect. Dis. 30:466-472.
107. Gardam, M. A., et al. 2002. Is surveillance for multidrug-resistant Enterobacteriaceae an effective infection control strategy in the absence of an outbreak? J. Infect. Dis. 186:1754-1760.
108. Garey, K. W., et al. 2008. Peripartum Clostridium difficile infection: case series and review of the literature. Am. J. Obstet. Gynecol. 199:332-337.
109. Garner, J. S., W. R. Jarvis, T. G. Emori, T. C. Horan, and J. M. Hughes. 1988. CDC definitions for nosocomial infections, 1988. Am. J. Infect. Control 16:128-140.
110. Gaynes, R., and J. R. Edwards. 2005. Overview of nosocomial infections caused by Gram-negative bacilli. Clin. Infect. Dis. 41:848-854.
111. Gebo, K. A., et al. 2002. Pseudo-outbreak of Mycobacterium fortuitum on a human immunodeficiency virus ward: transient respiratory tract colonization from a contaminated ice machine. Clin. Infect. Dis. 35:32-38.
112. Giske, C. G., D. L. Monnet, O. Cars, and Y. Carmeli. 2008. Clinical and economic impact of common multidrug-resistant Gram-negative bacilli. Antimicrob. Agents Chemother. 52:813-821.
113. Goldmann, D. A. 2002. Blood-borne pathogens and nosocomial infections. J. Allergy Clin. Immunol. 110:S21-S26.
114. Gordin, F. M., M. E. Schultz, R. A. Huber, and J. A. Gill. 2005. Reduction in nosocomial transmission of drug-resistant bacteria after introduction of an alcohol-based handrub. Infect. Control Hosp. Epidemiol. 26:650-653.
115. Gorwitz, R. J., et al. 2008. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J. Infect. Dis. 197:1226-1234.
116. Grady, G. F., et al. 1978. Hepatitis B immune globulin for accidental exposures among medical personnel: final report of a multicenter controlled trial. J. Infect. Dis. 138:625-638.
117. Grayson, M. L., et al. 1991. Increasing resistance to beta-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution. Antimicrob. Agents Chemother. 35:2180-2184.
118. Hajjeh, R. A., et al. 2004. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J. Clin. Microbiol. 42:1519-1527.
119. Hajjeh, R. A., and D. W. Warnock. 2001. Invasive aspergillosis and the environment - rethinking our approach to prevention. Clin. Infect. Dis. 33:1549-1552.
120. Haley, R. W., et al. 1985. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am. J. Epidemiol. 121:182-205.
121. Haley, R. W., et al. 1985. Update from the SENIC project. Hospital infection control: recent progress and opportunities under prospective payment. Am. J. Infect. Control 13:97-108.
122. Haley, R. W., D. Quade, H. E. Freeman, and J. V. Bennett. 1980. The SENIC Project. Study on the efficacy of nosocomial infection control (SENIC Project). Summary of study design. Am. J. Epidemiol. 111:472-485.
123. Hall, C. B. 2000. Nosocomial respiratory syncytial virus infections: the "Cold War" has not ended. Clin. Infect. Dis. 31:590-596.
124. Hall, C. B., A. E. Kopelman, R. G. Douglas, Jr., J. M. Geiman, and M. P. Meagher. 1979. Neonatal respiratory syncytial virus infection. N. Engl. J. Med. 300:393-396.
125. Hall, C. B., et al. 1986. Respiratory syncytial viral infection in children with compromised immune function. N. Engl. J. Med. 315:77-81.
126. Harbarth, S., et al. 1999. Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 43:1412-1416.
127. Harbarth, S., et al. 2008. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 299:1149-1157.
128. Harper, S. A., et al. 2009. Seasonal influenza in adults and children - diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin. Infect. Dis. 48:1003-1032.
129. Harris, A. D., et al. 2007. How important is patient-to-patient transmission in extended-spectrum beta-lactamase Escherichia coli acquisition. Am. J. Infect. Control 35:97-101.
130. Harris, A. D., J. C. McGregor, and J. P. Furuno. 2006. What infection control interventions should be undertaken to control multidrug-resistant Gram-negative bacteria? Clin. Infect. Dis. 43(Suppl. 2):S57-S61.
131. Harris, A. D., et al. 2007. Patient-to-patient transmission is important in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae acquisition. Clin. Infect. Dis. 45:1347-1350.
132. Hawkey, P. M., and A. M. Jones. 2009. The changing epidemiology of resistance. J. Antimicrob. Chemother. 64(Suppl. 1):i3-i10.
133. Henderson, D. K. 2003. Managing occupational risks for hepatitis C transmission in the health care setting. Clin. Microbiol. Rev. 16:546-568.
134. Henderson, D. K., et al. 2010. SHEA guideline for management of healthcare workers who are infected with hepatitis B virus, hepatitis C virus, and/or human immunodeficiency virus. Infect. Control Hosp. Epidemiol. 31:203-232.
135. Heyland, D. K., D. J. Cook, L. Griffith, S. P. Keenan, and C. Brun-Buisson. 1999. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am. J. Respir. Crit. Care Med. 159:1249-1256.
136. Hidron, A. I., et al. 2008. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections. Annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect. Control Hosp. Epidemiol. 29:996-1011.
137. Holmberg, S. D., S. L. Solomon, and P. A. Blake. 1987. Health and economic impacts of antimicrobial resistance. Rev. Infect. Dis. 9:1065-1078.
138. Hopkins, C. C., D. J. Weber, and R. H. Rubin. 1989. Invasive aspergillus infection: possible non-ward common source within the hospital environment. J. Hosp. Infect. 13:19-25.
139. Horan, T. C., M. Andrus, and M. A. Dudeck. 2008. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am. J. Infect. Control 36:309-332.
140. Hu, L., A. Umeda, and K. Amako. 1995. Typing of Staphylococcus epidermidis colonizing in human nares by pulsed-field gel electrophoresis. Microbiol. Immunol. 39:315-319.
141. Huang, S. S., R. Datta, and R. Platt. 2006. Risk of acquiring antibioticresistant bacteria from prior room occupants. Arch. Intern. Med. 166:1945-1951.
142. Huang, S. S., and R. Platt. 2003. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin. Infect. Dis. 36:281-285.
143. Huang, S. S., et al. 2007. Improving methicillin-resistant Staphylococcus aureus surveillance and reporting in intensive care units. J. Infect. Dis. 195:330-338.
144. Huang, S. S., et al. 2006. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillinresistant Staphylococcus aureus bacteremia. Clin. Infect. Dis. 43:971-978.
145. Huebner, J., and D. A. Goldmann. 1999. Coagulase-negative staphylococci: role as pathogens. Annu. Rev. Med. 50:223-236.
146. Hughes, J. M. 1988. Study on the efficacy of nosocomial infection control (SENIC Project): results and implications for the future. Chemotherapy 34:553-561.
147. Hughes, W. T., et al. 1997. 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America. Clin. Infect. Dis. 25:551-573.
148. Hunter, K. D., J. Gibson, P. Lockhart, A. Pithie, and J. Bagg. 1998. Fluconazole-resistant Candida species in the oral flora of fluconazole-exposed HIV-positive patients. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 85:558-564.
149. Hurt, A. C., R. Alexander, J. Hibbert, N. Deed, and I. G. Barr. 2007. Performance of six influenza rapid tests in detecting human influenza in clinical specimens. J. Clin. Virol. 39:132-135.
150. Iwamoto, M., et al. 2003. Transmission of West Nile virus from an organ donor to four transplant recipients. N. Engl. J. Med. 348:2196-2203.
151. Iwen, P. C., et al. 1993. Nosocomial invasive aspergillosis in lymphoma patients treated with bone marrow or peripheral stem cell transplants. Infect. Control Hosp. Epidemiol. 14:131-139.
152. Jarvis, W. R. 1995. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin. Infect. Dis. 20:1526-1530.
153. Jarvis, W. R. 1995. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. Am. J. Infect. Control 23:146-151.
154. Jarvis, W. R. 2007. The Lowbury Lecture. The United States approach to strategies in the battle against healthcare-associated infections, 2006: transitioning from benchmarking to zero tolerance and clinician accountability. J. Hosp. Infect. 65(Suppl. 2):3-9.
155. Jensen, P. A., L. A. Lambert, M. F. Iademarco, and R. Ridzon. 2005. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recommend. Rep. 54:1-141.
156. Johnson, J. K., et al. 2009. The role of patient-to-patient transmission in the acquisition of imipenem-resistant Pseudomonas aeruginosa colonization in the intensive care unit. J. Infect. Dis. 200:900-905.
157. Johnston, C. P., et al. 2007. Outbreak management and implications of a nosocomial norovirus outbreak. Clin. Infect. Dis. 45:534-540.
158. Joint Commission. 2003. Comprehensive accreditation manual for hospitals: the official handbook. The Joint Commission, Oakbrook Terrace, IL.
159. Joint Commission. 2010. National patient safety goals. The Joint Commission, Oakbrook Terrace, IL. http://www.jointcommission.org/patientsafety/ nationalpatientsafetygoals/.
160. Joint Commission on Accreditation of Healthcare Organizations. 1976. Accreditation manual for hospitals. Joint Commission on Accreditation of Healthcare Organizations, Chicago, IL.
161. Kallen, A. J., A. I. Hidron, J. Patel, and A. Srinivasan. 2010. Multidrug resistance among Gram-negative pathogens that caused healthcare-associated infections reported to the National Healthcare Safety Network, 2006-2008. Infect. Control Hosp. Epidemiol. 31:528-531.
162. Kallen, A. J., et al. 2010. Health care-associated invasive MRSA infections, 2005-2008. JAMA 304:641-648.
163. Kampf, G., D. Grotheer, and J. Steinmann. 2005. Efficacy of three ethanolbased hand rubs against feline calicivirus, a surrogate virus for norovirus. J. Hosp. Infect. 60:144-149.
164. Karanfil, L. V., et al. 1999. Reducing the rate of nosocomially transmitted respiratory syncytial virus. Am. J. Infect. Control 27:91-96.
165. Karlowsky, J. A., G. G. Zhanel, K. A. Klym, D. J. Hoban, and A. M. Kabani. 1997. Candidemia in a Canadian tertiary care hospital from 1976 to 1996. Diagn. Microbiol. Infect. Dis. 29:5-9.
166. Karthikeyan, K., M. A. Thirunarayan, and P. Krishnan. 2010. Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii from India. J. Antimicrob. Chemother. 65:2253-2254.
167. Katzenstein, T. L., et al. 1999. Nosocomial HIV-transmission in an outpatient clinic detected by epidemiological and phylogenetic analyses. AIDS 13:1737-1744.
168. Kirkland, K. B., and J. M. Weinstein. 1999. Adverse effects of contact isolation. Lancet 354:1177-1178.
169. Klimowski, L. L., C. Rotstein, and K. M. Cummings. 1989. Incidence of nosocomial aspergillosis in patients with leukemia over a twenty-year period. Infect. Control Hosp. Epidemiol. 10:299-305.
170. Kloos, W. E., and T. L. Bannerman. 1994. Update on clinical significance of coagulase-negative staphylococci. Clin. Microbiol. Rev. 7:117-140.
171. Kluytmans, J., A. van Belkum, and H. Verbrugh. 1997. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin. Microbiol. Rev. 10:505-520.
172. Kochar, S., et al. 2009. Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae. Infect. Control Hosp. Epidemiol. 30:447-452.
173. Kohn, L. T., J. M. Corrigan, and M. S. Donaldson. (ed.). 2000. To err is human: building a safer health system. National Academies Press, Washington, DC.
174. Krawczynski, K., et al. 1996. Effect of immune globulin on the prevention of experimental hepatitis C virus infection. J. Infect. Dis. 173:822-828.
175. Kretsinger, K., et al. 2006. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recommend. Rep. 55:1-37.
176. Kumarasamy, K. K., et al. 2010. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect. Dis. 10:597-602.
177. Larsen, A. R., et al. 2009. Emergence and characterization of communityassociated methicillin-resistant Staphyloccocus aureus infections in Denmark, 1999 to 2006. J. Clin. Microbiol. 47:73-78.
178. Lautenbach, E., W. B. Bilker, and P. J. Brennan. 1999. Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality. Infect. Control Hosp. Epidemiol. 20:318-323.
179. Lautenbach, E., J. B. Patel, W. B. Bilker, P. H. Edelstein, and N. O. Fishman. 2001. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin. Infect. Dis. 32:1162-1171.
180. Lautenbach, E., and R. E. Polk. 2007. Resistant Gram-negative bacilli: a neglected healthcare crisis? Am. J. Health Syst. Pharm. 64:S3-S21.
181. Leavitt, A., S. Navon-Venezia, I. Chmelnitsky, M. J. Schwaber, and Y. Carmeli. 2007. Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital. Antimicrob. Agents Chemother. 51:3026-3029.
182. Leclair, J. M., J. Freeman, B. F. Sullivan, C. M. Crowley, and D. A. Goldmann. 1987. Prevention of nosocomial respiratory syncytial virus infections
183. Lin, M. Y., et al. 2005. Prior antimicrobial therapy and risk for hospitalacquired Candida glabrata and Candida krusei fungemia: a case-case-control study. Antimicrob. Agents Chemother. 49:4555-4560.
184. Linnemann, C. C., Jr., N. Ramundo, P. H. Perlstein, S. D. Minton, and G. S. Englender. 1975. Use of pertussis vaccine in an epidemic involving hospital staff. Lancet ii:540-543.
185. Liverman, C. T., T. A. Harris, M. E. B. Rogers, and K. I. Shine (ed.). 2009. Respiratory protection for healthcare workers in the workplace against novel H1N1: a letter report. National Academies Press, Washington, DC.
186. Lo, E., et al. 2008. Strategies to prevent catheter-associated urinary tract infections in acute care hospitals. Infect. Control Hosp. Epidemiol. 29(Suppl. 1):S41-S50.
187. Loeb, M., et al. 2009. Surgical mask vs N95 respirator for preventing influenza among health care workers: a randomized trial. JAMA 302:1865-1871.
188. Lolans, K., T. W. Rice, L. S. Munoz-Price, and J. P. Quinn. 2006. Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40. Antimicrob. Agents Chemother. 50: 2941-2945.
189. Loo, V. G., et al. 1996. Control of construction-associated nosocomial aspergillosis in an antiquated hematology unit. Infect. Control Hosp. Epidemiol. 17:360-364.
190. Lowy, F. D. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339: 520-532.
191. Lucas, G. M., et al. 1998. Vancomycin-resistant and vancomycin- susceptible enterococcal bacteremia: comparison of clinical features and outcomes. Clin. Infect. Dis. 26:1127-1133.
192. Lucet, J. C., et al. 2005. Successful long-term program for controlling methicillin-resistant Staphylococcus aureus in intensive care units. Intensive Care Med. 31:1051-1057.
193. Luzar, M. A., et al. 1990. Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis. N. Engl. J. Med. 322:505-509.
194. Lyras, D., et al. 2009. Toxin B is essential for virulence of Clostridium difficile. Nature 458:1176-1179.
195. Madge, P., J. Y. Paton, J. H. McColl, and P. L. Mackie. 1992. Prospective controlled study of four infection-control procedures to prevent nosocomial infection with respiratory syncytial virus. Lancet 340:1079-1083.
196. Maheshwari, A., S. Ray, and P. J. Thuluvath. 2008. Acute hepatitis C. Lancet 372:321-332.
197. Mainous, M. R., P. A. Lipsett, and M. O'Brien. 1997. Enterococcal bacteremia in the surgical intensive care unit. Does vancomycin resistance affect mortality? The Johns Hopkins SICU Study Group. Arch. Surg. 132:76-81.
198. Maltezou, H. C. 2008. Nosocomial influenza: new concepts and practice. Curr. Opin. Infect. Dis. 21:337-343.
199. Maltezou, H. C., and M. Drancourt. 2003. Nosocomial influenza in children. J. Hosp. Infect. 55:83-91.
200. Maragakis, L. L., and T. M. Perl. 2008. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin. Infect. Dis. 46:1254-1263.
201. Maraki, S., et al. 2001. Prospective evaluation of the impact of amoxicillin, clarithromycin and their combination on human gastrointestinal colonization by Candida species. Chemotherapy 47:215-218.
202. Marr, K. A., R. A. Carter, M. Boeckh, P. Martin, and L. Corey. 2002. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 100:4358-4366.
203. Marr, K. A., R. A. Carter, F. Crippa, A. Wald, and L. Corey. 2002. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 34:909-917.
204. Marr, K. A., K. Seidel, T. C. White, and R. A. Bowden. 2000. Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole. J. Infect. Dis. 181: 309-316.
205. Marschall, J., et al. 2008. Strategies to prevent central line-associated bloodstream infections in acute care hospitals. Infect. Control Hosp. Epidemiol. 29(Suppl. 1):S22-S30.
206. Martin, M. A., M. A. Pfaller, and R. P. Wenzel. 1989. Coagulase-negative staphylococcal bacteremia. Mortality and hospital stay. Ann. Intern. Med. 110:9-16.
207. Martino, P., et al. 1989. Candida colonization and systemic infection in neutropenic patients. A retrospective study. Cancer 64:2030-2034.
208. McDonald, L. C., et al. 2005. An epidemic, toxin gene-variant strain of Clostridium difficile. N. Engl. J. Med. 353:2433-2441.
209. McDonald, L. C., M. Owings, and D. B. Jernigan. 2006. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg. Infect. Dis. 12:409-415.
210. McFarland, L. V., M. E. Mulligan, R. Y. Kwok, and W. E. Stamm. 1989. Nosocomial acquisition of Clostridium difficile infection. N. Engl. J. Med. 320:204-210.
211. McKibben, L., G. Fowler, T. Horan, and P. J. Brennan. 2006. Ensuring rational public reporting systems for health care-associated infections: systematic literature review and evaluation recommendations. Am. J. Infect. Control 34:142-149.
212. McKibben, L., et al. 2005. Guidance on public reporting of healthcareassociated infections: recommendations of the Healthcare Infection Control Practices Advisory Committee. Am. J. Infect. Control 33:217-226.
213. Menzies, D., A. Fanning, L. Yuan, and M. Fitzgerald. 1995. Tuberculosis among health care workers. N. Engl. J. Med. 332:92-98.
214. Mermel, L. A., S. L. Josephson, C. H. Giorgio, J. Dempsey, and S. Parenteau. 1995. Association of Legionnaires' disease with construction: contamination of potable water? Infect. Control Hosp. Epidemiol. 16:76-81.
215. Mest, D. R., D. H. Wong, K. J. Shimoda, M. E. Mulligan, and S. E. Wilson. 1994. Nasal colonization with methicillin-resistant Staphylococcus aureus on admission to the surgical intensive care unit increases the risk of infection. Anesth. Analg. 78:644-650.
216. Meyers, H., et al. 2002. An outbreak of Mycobacterium chelonae infection following liposuction. Clin. Infect. Dis. 34:1500-1507.
217. Michelin, A., and D. K. Henderson. 2010. Infection control guidelines for prevention of health care-associated transmission of hepatitis B and C viruses. Clin. Liver Dis. 14:119-136.
218. Miller, G., S. Randolph, and J. E. Patterson. 2008. Responding to simulated pandemic influenza in San Antonio, Texas. Infect. Control Hosp. Epidemiol. 29:320-326.
219. Molinari, N. A., et al. 2007. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 25:5086-5096.
220. Muder, R. R., C. Brennen, S. D. Drenning, J. E. Stout, and M. M. Wagener. 1997. Multiply antibiotic-resistant Gram-negative bacilli in a long-term-care facility: a case-control study of patient risk factors and prior antibiotic use. Infect. Control Hosp. Epidemiol. 18:809-813.
221. Muir, A., and M. J. Weinbren. 2010. New Delhi metallo-beta-lactamase: a cautionary tale. J. Hosp. Infect. 75:239-240.
222. Mullins, J., R. Harvey, and A. Seaton. 1976. Sources and incidence of airborne Aspergillus fumigatus (Fres). Clin. Allergy 6:209-217.
223. Munoz-Price, L. S. 2009. Long-term acute care hospitals. Clin. Infect. Dis. 49:438-443.
224. Munoz-Price, L. S., et al. 2010. Successful control of an outbreak of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae at a longterm acute care hospital. Infect. Control Hosp. Epidemiol. 31:341-347.
225. Muto, C. A., et al. 2003. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect. Control Hosp. Epidemiol. 24:362-386.
226. Mylonakis, E., T. F. Barlam, T. Flanigan, and J. D. Rich. 1998. Pulmonary aspergillosis and invasive disease in AIDS: review of 342 cases. Chest 114:251-262.
227. Nakashima, A. K., and P. L. Fleming. 2003. HIV/AIDS surveillance in the United States, 1981-2001. J. Acquir. Immune Defic. Syndr. 32(Suppl. 1): S68-S85.
228. National Nosocomial Infections Surveillance System. 2004. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am. J. Infect. Control 32:470-485.
229. National Nosocomial Infections Surveillance System. 2001. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992-June 2001, issued August 2001. Am. J. Infect. Control 29: 404-421.
230. Nennig, M. E., H. R. Shinefield, K. M. Edwards, S. B. Black, and B. H. Fireman. 1996. Prevalence and incidence of adult pertussis in an urban population. JAMA 275:1672-1674.
231. Neuhauser, M. M., et al. 2003. Antibiotic resistance among Gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA 289:885-888.
232. Nicasio, A. M., J. L. Kuti, and D. P. Nicolau. 2008. The current state of multidrug-resistant Gram-negative bacilli in North America. Pharmacotherapy 28:235-249.
233. Noakes, T. D., J. Borresen, T. Hew-Butler, M. I. Lambert, and E. Jordaan. 2008. Semmelweis and the aetiology of puerperal sepsis 160 years on: an historical review. Epidemiol. Infect. 136:1-9.
234. Nseir, S., et al. 2010. Accuracy of American Thoracic Society/Infectious Diseases Society of America criteria in predicting infection or colonization with multidrug-resistant bacteria at intensive-care unit admission. Clin. Microbiol. Infect. 16:902-908.
235. Nucci, M., et al. 1995. Fungal infections in neutropenic patients. A 8-year prospective study. Rev. Inst. Med. Trop. Sao Paulo 37:397-406.
236. O'Brien, J. A., B. J. Lahue, J. J. Caro, and D. M. Davidson. 2007. The emerging infectious challenge of Clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. Infect. Control Hosp. Epidemiol. 28:1219-1227.
237. Occupational Safety and Health Administration. 1991. Occupational exposure to bloodborne pathogens - OSHA. Final rule. Fed. Regist. 56:64004-64182.
238. Occupational Safety and Health Administration. 2010. Occupational safety and health standards. Occupational Safety and Health Administration, Washington, DC. http://www.osha.gov/pls/oshaweb/owadisp.show-document?p-table= STANDARDS&p-id=10051.
239. Olson, B., R. A. Weinstein, C. Nathan, W. Chamberlin, and S. A. Kabins. 1984. Epidemiology of endemic Pseudomonas aeruginosa: why infection control efforts have failed. J. Infect. Dis. 150:808-816.
240. O'Malley, C. A. 2009. Infection control in cystic fibrosis: cohorting, crosscontamination, and the respiratory therapist. Respir. Care 54:641-657.
241. Oren, I., N. Haddad, R. Finkelstein, and J. M. Rowe. 2001. Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: before and after chemoprophylaxis and institution of HEPA filters. Am. J. Hematol. 66:257-262.
242. Ortega, B., A. B. Groeneveld, and C. Schultsz. 2004. Endemic multidrugresistant Pseudomonas aeruginosa in critically ill patients. Infect. Control Hosp. Epidemiol. 25:825-831.
243. Palmer, L. B. 2009. Ventilator-associated infection. Curr. Opin. Pulm. Med. 15:230-235.
244. Panlilio, A. L., D. M. Cardo, L. A. Grohskopf, W. Heneine, and C. S. Ross. 2005. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis. MMWR Recommend. Rep. 54:1-17.
245. Panlilio, A. L., et al. 1995. Serosurvey of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among hospital-based surgeons. Serosurvey Study Group. J. Am. Coll. Surg. 180:16-24.
246. Paterson, D. L. 2008. Impact of antibiotic resistance in Gram-negative bacilli on empirical and definitive antibiotic therapy. Clin. Infect. Dis. 47(Suppl. 1):S14-S20.
247. Pelz, R. K., et al. 2002. Vancomycin-sensitive and vancomycin-resistant enterococcal infections in the ICU: attributable costs and outcomes. Intensive Care Med. 28:692-697.
248. Perencevich, E. N., et al. 2007. Raising standards while watching the bottom line: making a business case for infection control. Infect. Control Hosp. Epidemiol. 28:1121-1133.
249. Perl, T. M., and R. Chaiwarith. 2010. Surveillance: an overview, p. 111-142. In E. Lautenbach, K. F. Woeltje, and P. N. Malani (ed.), Practical healthcare epidemiology, 3rd ed. University of Chicago Press, Chicago, IL.
250. Perl, T. M., et al. 2002. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N. Engl. J. Med. 346:1871-1877.
251. Perl, T. M., and J. E. Golub. 1998. New approaches to reduce Staphylococcus aureus nosocomial infection rates: treating S. aureus nasal carriage. Ann. Pharmacother. 32:S7-S16.
252. Perl, T. M., and M. C. Roy. 1995. Postoperative wound infections: risk factors and role of Staphylococcus aureus nasal carriage. J. Chemother. 7(Suppl. 3):29-35.
253. Perlroth, J., B. Choi, and B. Spellberg. 2007. Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med. Mycol. 45:321-346.
254. Perraud, M., et al. 1987. Invasive nosocomial pulmonary aspergillosis: risk factors and hospital building works. Epidemiol. Infect. 99:407-412.
255. Petrosillo, N., L. Pagani, and G. Ippolito. 2003. Nosocomial infections in HIV-positive patients: an overview. Infection 31(Suppl. 2):28-34.
256. Petrosillo, N., et al. 1999. Nosocomial infections in HIV infected patients. Gruppo HIV e Infezioni Ospedaliere. AIDS 13:599-605.
257. Petrosillo, N., et al. 2002. Nosocomial bloodstream infections among human immunodeficiency virus-infected patients: incidence and risk factors. Clin. Infect. Dis. 34:677-685.
258. Pfaller, M. A. 1995. Epidemiology of candidiasis. J. Hosp. Infect. 30(Suppl.):329-338.
259. Phillips, M. S., and C. F. von Reyn. 2001. Nosocomial infections due to nontuberculous mycobacteria. Clin. Infect. Dis. 33:1363-1374.
260. Pittet, D., et al. 1999. Prevalence and risk factors for nosocomial infections in four university hospitals in Switzerland. Infect. Control Hosp. Epidemiol. 20:37-42.
261. Pittet, D., et al. 2000. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme. Lancet 356:1307-1312.
262. Pittet, D., D. Tarara, and R. P. Wenzel. 1994. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 271:1598-1601.
263. Poch, D. S., and D. E. Ost. 2009. What are the important risk factors for healthcare-associated pneumonia? Semin. Respir. Crit. Care Med. 30:26-35.
264. Popovich, K. J., R. A. Weinstein, and B. Hota. 2008. Are communityassociated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains? Clin. Infect. Dis. 46:787-794.
265. Pronovost, P., et al. 2006. An intervention to decrease catheter-related bloodstream infections in the ICU. N. Engl. J. Med. 355:2725-2732.
266. Pujol, M., et al. 1996. Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. Am. J. Med. 100:509-516.
267. Quale, J., et al. 1996. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin. Infect. Dis. 23:1020-1025.
268. Raad, I., et al. 2002. Masking of neutropenic patients on transport from hospital rooms is associated with a decrease in nosocomial aspergillosis during construction. Infect. Control Hosp. Epidemiol. 23:41-43.
269. Rahman, M., et al. 2007. Performance of Directigen flu A+B enzyme immunoassay and direct fluorescent assay for detection of influenza infection during the 2004-2005 season. Diagn. Microbiol. Infect. Dis. 58:413-418.
270. Rakita, R. M., B. A. Hagar, P. Crome, and J. K. Lammert. 2010. Mandatory influenza vaccination of healthcare workers: a 5-year study. Infect. Control Hosp. Epidemiol. 31:881-888.
271. Ramirez-Amador, V., S. Silverman, Jr., P. Mayer, M. Tyler, and J. Quivey. 1997. Candidal colonization and oral candidiasis in patients undergoing oral and pharyngeal radiation therapy. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 84:149-153.
272. Ramsey, A. M., and M. D. Zilberberg. 2009. Secular trends of hospitalization with vancomycin-resistant enterococcus infection in the United States, 2000-2006. Infect. Control Hosp. Epidemiol. 30:184-186.
273. Resar, R., et al. 2005. Using a bundle approach to improve ventilator care processes and reduce ventilator-associated pneumonia. Jt. Comm. J. Qual. Patient Saf. 31:243-248.
274. Reuter, S., A. Sigge, H. Wiedeck, and M. Trautmann. 2002. Analysis of transmission pathways of Pseudomonas aeruginosa between patients and tap water outlets. Crit. Care Med. 30:2222-2228.
275. Rice, L. B. 2006. Antimicrobial resistance in Gram-positive bacteria. Am. J. Med. 119:S11-S119.
276. Rice, L. B. 2006. Antimicrobial resistance in Gram-positive bacteria. Am. J. Infect. Control 34:S11-S19, S64-S73.
277. Roberts, R. R., et al. 2009. Hospital and societal costs of antimicrobialresistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin. Infect. Dis. 49:1175-1184.
278. Robicsek, A., et al. 2008. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann. Intern. Med. 148:409-418.
279. Robicsek, A., J. L. Beaumont, R. B. Thomson, Jr., G. Govindarajan, and L. R. Peterson. 2009. Topical therapy for methicillin-resistant Staphylococcus aureus colonization: impact on infection risk. Infect. Control Hosp. Epidemiol. 30:623-632.
280. Rolain, J. M., P. Parola, and G. Cornaglia. 2010. New Delhi metallo-betalactamase (NDM-1): towards a new pandemia? Clin. Microbiol. Infect. 15(Suppl. 2):98-99.
281. Roth, V. R., and M. Loeb. 2010. Administering an infection prevention program, p. 403-406. In E. Lautenbach, K. F. Woeltje, and P. N. Malani (ed.), Practical healthcare epidemiology, 3rd ed. University of Chicago Press, Chicago, IL.
282. Ruhl, L., and L. A. Herwaldt. 2010. Infection prevention in construction and renovation, p. 439-462. In E. Lautenbach, K. F. Woeltje, and P. N. Malani (ed.), Practical healthcare epidemiology, 3rd ed. University of Chicago Press, Chicago, IL.
283. Rutala, W. A. 1996. APIC guideline for selection and use of disinfectants. 1994, 1995, and 1996 APIC Guidelines Committee. Association for Professionals in Infection Control and Epidemiology, Inc. Am. J. Infect. Control 24:313-342.
284. Rutala, W. A, and D. Weber. 2008. Healthcare Infection Control Practices Advisory Committee. Guideline for disinfection and sterilization in healthcare facilities. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/hicpac/Disinfection-Sterilization/table-10.html.
285. Rutala, W. A., and D. J. Weber. 2004. Disinfection and sterilization in health care facilities: what clinicians need to know. Clin. Infect. Dis. 39: 702-709.
286. Safdar, N., C. Dezfulian, H. R. Collard, and S. Saint. 2005. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit. Care Med. 33:2184-2193.
287. Safdar, N., J. Marx, N. A. Meyer, and D. G. Maki. 2006. Effectiveness of preemptive barrier precautions in controlling nosocomial colonization and infection by methicillin-resistant Staphylococcus aureus in a burn unit. Am. J. Infect. Control 34:476-483.
288. Said, M. A., T. M. Perl, and C. L. Sears. 2008. Healthcare epidemiology. Gastrointestinal flu: norovirus in health care and long-term care facilities. Clin. Infect. Dis. 47:1202-1208.
289. Saiman, L., and J. Siegel. 2003. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. Infect. Control Hosp. Epidemiol. 24:S6-S52.
290. Saint, S., L. A. Higgins, B. K. Nallamothu, and C. Chenoweth. 2003. Do physicians examine patients in contact isolation less frequently? A brief report. Am. J. Infect. Control 31:354-356.
291. Salgado, C. D., and B. M. Farr. 2006. What proportion of hospital patients colonized with methicillin-resistant Staphylococcus aureus are identified by clinical microbiological cultures? Infect. Control Hosp. Epidemiol. 27:116-121.
292. Sallah, S., J. Y. Wan, N. P. Nguyen, P. Vos, and G. Sigounas. 2001. Analysis of factors related to the occurrence of chronic disseminated candidiasis in patients with acute leukemia in a non-bone marrow transplant setting: a follow-up study. Cancer 92:1349-1353.
293. Sanford, M. D., A. F. Widmer, M. J. Bale, R. N. Jones, and R. P. Wenzel. 1994. Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus. Clin. Infect. Dis. 19:1123-1128.
294. Scheckler, W. E., et al. 1998. Requirements for infrastructure and essential activities of infection control and epidemiology in hospitals: a consensus panel report. Society for Healthcare Epidemiology of America. Am. J. Infect. Control 26:47-60.
295. Scheckler, W. E., et al. 1998. Requirements for infrastructure and essential activities of infection control and epidemiology in hospitals: a consensus panel report. Society for Healthcare Epidemiology of America. Infect. Control Hosp. Epidemiol. 19:114-124.
296. Sendid, B., et al. 2006. Candidaemia and antifungal therapy in a French University Hospital: rough trends over a decade and possible links. BMC Infect. Dis. 6:80.
297. Reference deleted.
298. Sherertz, R. J., et al. 1987. Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients. Am. J. Med. 83:709-718.
299. Shojania, K. G., B. W. Duncan, K. M. McDonald, R. M. Wachter, and A. J. Markowitz. 2001. Making health care safer: a critical analysis of patient safety practices. Evid. Rep. Technol. Assess. (Summ.) 2001:1-668.
300. Shurland, S., M. Zhan, D. D. Bradham, and M. C. Roghmann. 2007. Comparison of mortality risk associated with bacteremia due to methicillinresistant and methicillin-susceptible Staphylococcus aureus. Infect. Control Hosp. Epidemiol. 28:273-279.
301. Siegel, J. D., et al. 2007. 2007 guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings. Am. J. Infect. Control 35(Suppl. 2):S65-S164.
302. Siegel, J. D., E. Rhinehart, M. Jackson, and L. Chiarello. 2007. Management of multidrug-resistant organisms in healthcare settings, 2006. Am. J. Infect. Control 35(Suppl. 2):S165-S193.
303. Simor, A. E., et al. 2007. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clin. Infect. Dis. 44:178-185.
304. Skov, R. L., and K. S. Jensen. 2009. Community-associated meticillinresistant Staphylococcus aureus as a cause of hospital-acquired infections. J. Hosp. Infect. 73:364-370.
305. Smith, D. W. 1999. Decreased antimicrobial resistance after changes in antibiotic use. Pharmacotherapy 19:129S-132S.
306. Smith, T. L., P. C. Iwen, S. B. Olson, and M. E. Rupp. 1998. Environmental contamination with vancomycin-resistant enterococci in an outpatient setting. Infect. Control Hosp. Epidemiol. 19:515-518.
307. Smith-Moland, E. S., et al. 2003. Plasmid-mediated, carbapenem- hydrolysing beta-lactamase, KPC-2, in Klebsiella pneumoniae isolates. J. Antimicrob. Chemother. 51:711-714.
308. Snider, D. E., Jr., and W. L. Roper. 1992. The new tuberculosis. N. Engl. J. Med. 326:703-705.
309. Society for Healthcare Epidemiology of America. 2009. Interim guidance on infection control precautions for novel swine-origin influenza A H1N1 in healthcare facilities. Society for Healthcare Epidemiology of America, Arlington, VA. www.shea-online.org/Assets/files/policy/061209-H1N1-Statement. pdf.
310. Song, X., A. Srinivasan, D. Plaut, and T. M. Perl. 2003. Effect of nosocomial vancomycin-resistant enterococcal bacteremia on mortality, length of stay, and costs. Infect. Control Hosp. Epidemiol. 24:251-256.
311. Spach, D. H., F. E. Silverstein, and W. E. Stamm. 1993. Transmission of infection by gastrointestinal endoscopy and bronchoscopy. Ann. Intern. Med. 118:117-128.
312. Srinivasan, A., and W. R. Jarvis. 2010. Outbreak investigations, p. 143-155. In E. Lautenbach, K. F. Woeltje, and P. N. Malani (ed.), Practical healthcare epidemiology, 3rd ed. University of Chicago Press, Chicago, IL.
313. Stelfox, H. T., D. W. Bates, and D. A. Redelmeier. 2003. Safety of patients isolated for infection control. JAMA 290:1899-1905.
314. St-Germain, G., et al. 2001. Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: results of a 2-year (1996 to 1998) multicenter surveillance study in Quebec, Canada. J. Clin. Microbiol. 39:949-953.
315. Stone, P. W., D. Braccia, and E. Larson. 2005. Systematic review of economic analyses of health care-associated infections. Am. J. Infect. Control 33:501-509.
316. Stone, P. W., et al. 2009. Staffing and structure of infection prevention and control programs. Am. J. Infect. Control 37:351-357.
317. Reference deleted.
318. Strausbaugh, L. J., J. D. Siegel, and R. A. Weinstein. 2006. Preventing transmission of multidrug-resistant bacteria in health care settings: a tale of 2 guidelines. Clin. Infect. Dis. 42:828-835.
319. Stroud, L., et al. 1997. Nosocomial infections in HIV-infected patients: preliminary results from a multicenter surveillance system (1989-1995). Infect. Control Hosp. Epidemiol. 18:479-485.
320. Szczech, L. A. 2001. Renal diseases associated with human immunodeficiency virus infection: epidemiology, clinical course, and management. Clin. Infect. Dis. 33:115-119.
321. Tacconelli, E., and M. A. Cataldo. 2008. Vancomycin-resistant enterococci (VRE): transmission and control. Int. J. Antimicrob. Agents 31:99-106.
322. Tambyah, P. A., V. Knasinski, and D. G. Maki. 2002. The direct costs of nosocomial catheter-associated urinary tract infection in the era of managed care. Infect. Control Hosp. Epidemiol. 23:27-31.
323. Taylor, M. E., and B. A. Oppenheim. 1998. Hospital-acquired infection in elderly patients. J. Hosp. Infect. 38:245-260.
324. Tellier, R. 2009. Aerosol transmission of influenza A virus: a review of new studies. J. R. Soc. Interface 6(Suppl. 6):S783-S790.
325. Tenke, P., et al. 2008. European and Asian guidelines on management and prevention of catheter-associated urinary tract infections. Int. J. Antimicrob. Agents 31(Suppl. 1):S68-S78.
326. Tenover, F. C., et al. 2010. Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches. J. Clin. Microbiol. 48:3719-3724.
327. Thio, C. L., et al. 2000. Refinements of environmental assessment during an outbreak investigation of invasive aspergillosis in a leukemia and bone marrow transplant unit. Infect. Control Hosp. Epidemiol. 21:18-23.
328. Tokars, J. I., et al. 1992. Percutaneous injuries during surgical procedures. JAMA 267:2899-2904.
329. Tokars, J. I., et al. 2004. The changing face of surveillance for health care-associated infections. Clin. Infect. Dis. 39:1347-1352.
330. U.S. Congress. 2007. Community and healthcare-associated infections reduction act of 2007. S.2278. 110th U.S. Congress, Washington, DC. http://www.govtrack.us/congress/bill.xpd?bill=s110-2278.
331. Vergis, E. N., et al. 2001. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. a prospective multicenter study. Ann. Intern. Med. 135:484-492.
332. Villegas, M. V., and A. I. Hartstein. 2003. Acinetobacter outbreaks, 1977-2000. Infect. Control Hosp. Epidemiol. 24:284-295.
333. Villegas, M. V., et al. 2006. First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America. Antimicrob. Agents Chemother. 50:2880-2882.
334. Viscidi, R., S. Willey, and J. G. Bartlett. 1981. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. Gastroenterology 81:5-9.
335. von Eiff, C., K. Becker, K. Machka, H. Stammer, and G. Peters. 2001. Nasal carriage as a source of Staphylococcus aureus bacteremia. N. Engl. J. Med. 344:11-16.
336. Wald, A., W. Leisenring, J. A. van Burik, and R. A. Bowden. 1997. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J. Infect. Dis. 175:1459-1466.
337. Wald, H. L., and A. M. Kramer. 2007. Nonpayment for harms resulting from medical care: catheter-associated urinary tract infections. JAMA 298: 2782-2784.
338. Wallace, J. M., et al. 1998. Risk factors and outcomes associated with identification of Aspergillus in respiratory specimens from persons with HIV disease. Pulmonary Complications of HIV Infection Study Group. Chest 114:131-137.
339. Warny, M., et al. 2005. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366:1079-1084.
340. Wasley, A., S. Grytdal, and K. Gallagher. 2008. Surveillance for acute viral hepatitis - United States, 2006. MMWR Surveill. Summ. 57:1-24.
341. Weber, D. J., and W. A. Rutala. 2001. Lessons from outbreaks associated with bronchoscopy. Infect. Control Hosp. Epidemiol. 22:403-408.
342. Weber, D. J., and W. A. Rutala. 1998. Pertussis: an underappreciated risk for nosocomial outbreaks. Infect. Control Hosp. Epidemiol. 19:825-828.
343. Weber, D. J., and R. P. Wenzel. 1997. Environmental issues and nosocomial infections, p. 491-514. In R. P. Wenzel (ed.), Prevention and control of nosocomial infections. Williams & Wilkins, Baltimore, MD.
344. Weber, S. G., et al. 2007. Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: position statement from the Joint SHEA and APIC Task Force. Infect. Control Hosp. Epidemiol. 28:249-260.
345. Weinke, T., R. Schiller, F. J. Fehrenbach, and H. D. Pohle. 1992. Association between Staphylococcus aureus nasopharyngeal colonization and septicemia in patients infected with the human immunodeficiency virus. Eur. J. Clin. Microbiol. Infect. Dis. 11:985-989.
346. Wenzel, R. P. 1995. The Lowbury Lecture. The economics of nosocomial infections. J. Hosp. Infect. 31:79-87.
347. Wenzel, R. P., C. A. Osterman, K. J. Hunting, and J. M. Gwaltney, Jr. 1976. Hospital-acquired infections. I. Surveillance in a university hospital. Am. J. Epidemiol. 103:251-260.
348. Wenzel, R. P., and T. M. Perl. 1995. The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection. J. Hosp. Infect. 31:13-24.
349. Wenzel, R. P., et al. 1983. Hospital-acquired infections in intensive care unit patients: an overview with emphasis on epidemics. Infect. Control 4:371-375.
350. Werner, B. G., and G. F. Grady. 1982. Accidental hepatitis-B- surfaceantigen-positive inoculations. Use of e antigen to estimate infectivity. Ann. Intern. Med. 97:367-369.
351. West, T. E., et al. 2006. Effect of targeted surveillance for control of methicillin-resistant Staphylococcus aureus in a community hospital system. Infect. Control Hosp. Epidemiol. 27:233-238.
352. Wey, S. B., M. Mori, M. A. Pfaller, R. F. Woolson, and R. P. Wenzel. 1989. Risk factors for hospital-acquired candidemia. A matched case-control study. Arch. Intern. Med. 149:2349-2353.
353. Wilson, L. S., et al. 2002. The direct cost and incidence of systemic fungal infections. Value Health 5:26-34.
354. Wisplinghoff, H., et al. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39:309-317.
355. Wisplinghoff, H., H. Seifert, R. P. Wenzel, and M. B. Edmond. 2003. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin. Infect. Dis. 36:1103-1110.
356. Wong, E. S., et al. 2005. Public disclosure of healthcare-associated infections: the role of the Society for Healthcare Epidemiology of America. Infect. Control Hosp. Epidemiol. 26:210-212.
357. World Health Organization. 2009. Infection prevention and control in health care for confirmed or suspected cases of pandemic (H1N1) 2009 and influenzalike illnesses. World Health Organization, Geneva, Switzerland. http://www.who.int/csr/resources/publications/SwineInfluenza-infectioncontrol. pdf.
358. Wright, M. O., et al. 2004. Preliminary assessment of an automated surveillance system for infection control. Infect. Control Hosp. Epidemiol. 25:325-332.
359. Wullt, M., I. Odenholt, and M. Walder. 2003. Activity of three disinfectants and acidified nitrite against Clostridium difficile spores. Infect. Control Hosp. Epidemiol. 24:765-768.
360. Yang, E. S., et al. 2010. Body site colonization in patients with communityassociated methicillin-resistant Staphylococcus aureus and other types of S. aureus skin infections. Clin. Microbiol. Infect. 16:425-431.
361. Yigit, H., et al. 2001. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 45:1151-1161.
362. Yokoe, D., et al. 2009. Infection prevention and control in health-care facilities in which hematopoietic cell transplant recipients are treated. Bone Marrow Transplant. 44:495-507.
363. Yokoe, D. S., and D. Classen. 2008. Improving patient safety through infection control: a new healthcare imperative. Infect. Control Hosp. Epidemiol. 29(Suppl. 1):S3-S11.
364. Yokoe, D. S., et al. 2008. A compendium of strategies to prevent healthcareassociated infections in acute care hospitals. Infect. Control Hosp. Epidemiol. 29(Suppl. 1):S12-S21.
365. Yong, D., et al. 2009. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob. Agents Chemother. 53:5046-5054.
366. Yu, V. L., et al. 1986. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis. N. Engl. J. Med. 315:91-96.
367. Zaoutis, T. E., et al. 2005. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin. Infect. Dis. 41:1232-1239.
368. Zhao, W. H., and Z. Q. Hu. 2010. Beta-lactamases identified in clinical isolates of Pseudomonas aeruginosa. Crit. Rev. Microbiol. 36:245-258.
369. Zhou, Q., C. Moore, S. Eden, A. Tong, and A. McGeer. 2008. Factors associated with acquisition of vancomycin-resistant enterococci (VRE) in roommate contacts of patients colonized or infected with VRE in a tertiary care hospital. Infect. Control Hosp. Epidemiol. 29:398-403.
370. Zimmerman, S. W., et al. 1991. Randomized controlled trial of prophylactic rifampin for peritoneal dialysis-related infections. Am. J. Kidney Dis. 18: 225-231.